DMXU Among Developed ETFs
End-of-day Nov 18, 2026 · 66 Developed ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −4.1% | −3.7% | −8.9% | +3.1% | +8.4% | +41.7% | +29.2% | — | +87.9% |
| Peer average | −0.9% | −3.4% | −2.8% | −5.3% | +7.0% | +11.1% | +60.2% | +47.8% | +142.6% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$27 of every $1,000 in DMXU is Samsung
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 005930.KSSamsung Electronics | Technology | 2.69% | $269.06 | 11K | $1.6M |
| 2 | ASML.ASAsml | Technology | 2.08% | $207.93 | 885 | $1.2M |
| 3 | 000660.KSSK Hynix | Technology | 1.65% | $164.72 | 1,163 | $954K |
| 4 | ROP.SWRoche AG Part | Healthcare | 1.37% | $137.14 | 1,641 | $794K |
| 5 | —Cash & Cash Equivalents | — | 1.35% | $134.73 | 0 | $780K |
| 6 | NOVN.SWNovartis AG-Reg | Healthcare | 1.20% | $120.44 | 4,392 | $698K |
| 7 | HSBA.LHsbc | Financial Services | 1.20% | $120.36 | 40K | $697K |
| 8 | SHEL.LShell | Energy | 1.13% | $113.18 | 14K | $656K |
| 9 | AZN.LAstraZeneca | Healthcare | 1.10% | $109.94 | 3,494 | $637K |
| 10 | NESN.SWNestle -Reg | Consumer Defensive | 1.07% | $107.03 | 5,998 | $620K |
| 11 | RY.TORoyal Bank of Canada | Financial Services | 1.03% | $103.11 | 3,037 | $597K |
| 12 | SIE.DESiemens AG-Reg | Industrials | 0.91% | $90.97 | 1,775 | $527K |
| 13 | SAP.DESAP SE | Technology | 0.87% | $86.81 | 2,268 | $503K |
| 14 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.83% | $82.66 | 23K | $479K |
| 15 | ALV.DEAllianz SE-Reg | Financial Services | 0.79% | $78.52 | 886 | $455K |
of the $687B in 67 Developed ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 005930.KS | Samsung Electronics | 2.69% |
| 2 | ASML.AS | Asml | 2.08% |
| 3 | 000660.KS | SK Hynix | 1.65% |
| 4 | ROP.SW | Roche AG Part | 1.37% |
| 5 | NOVN.SW | Novartis AG-Reg | 1.20% |
| 6 | HSBA.L | Hsbc | 1.20% |
| 7 | SHEL.L | Shell | 1.13% |
| 8 | AZN.L | AstraZeneca | 1.10% |
| 9 | NESN.SW | Nestle -Reg | 1.07% |
| 10 | RY.TO | Royal Bank of Canada | 1.03% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 18, 2026 | Jun 26, 2026 | $0.56 |
| Dec 19, 2025 | Dec 29, 2025 | $0.91 |
| Jun 20, 2025 | Jun 27, 2025 | $0.56 |
| Dec 20, 2024 | Dec 30, 2024 | $0.34 |
| Jun 21, 2024 | Jun 28, 2024 | $0.52 |
| Dec 15, 2023 | Dec 22, 2023 | $0.26 |
| Jun 23, 2023 | Jun 30, 2023 | $0.48 |
| Dec 16, 2022 | Dec 23, 2022 | $0.21 |
| Jun 24, 2022 | Jul 1, 2022 | $0.42 |
| Dec 17, 2021 | Dec 27, 2021 | $0.39 |
| Jun 25, 2021 | Jul 2, 2021 | $0.46 |
| Dec 18, 2020 | Dec 28, 2020 | $0.23 |